对月经前综合征的开放式安慰剂的有效性:一项随机对照试验
Antje Frey Nascimento1, Jens Gaab2, Bojana Degen2
1Division of Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, Basel, Switzerland antje.freynascimento@unibas.ch.
BMJ evidence-based medicine
|March 25, 2025
概括
与治疗逻辑相关的开放标签安慰剂 (OLP) 与通常治疗相比,有效地减少了月经前综合征 (PMS) 症状和干扰. 这种安全可接受的干预措施为PMS管理提供了新的治疗选择.
科学领域:
- 妇科 妇科医生 妇科
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
背景情况:
- 月经前综合征 (PMS) 显著影响女性的生活质量.
- 现有的PMS治疗方法存在局限性,需要新的治疗方法.
- 开放式安慰剂 (OLP) 是一种潜在的非药物干预.
研究的目的:
- 评估OLP在管理PMS症状中的有效性和安全性.
- 为了比较OLP与没有治疗的治疗逻辑与通常的治疗 (TAU).
主要方法:
- 在瑞士进行了一项随机对照试验,涉及150名被诊断患有PMS或月经前失调障碍的妇女.
- 参与者被分配到TAU,没有理由的OLP (OLP-),或有理由的OLP (OLP+),每天服用两个安慰剂药丸六周.
- 主要结局包括PMS症状强度和三个月经周期的干扰,通过不良事件评估安全性.
主要成果:
- 与TAU和OLP-.相比,具有治疗理由的OLP (OLP+) 显著降低了PMS症状强度和干扰,而不是TAU和OLP-.
- 在OLP和TAU之间没有观察到症状强度或干扰的显著差异.
- 在OLP干预中报告了高坚持率 (93.18%),只有四个非严重的不良事件被记录.
结论:
- 提供明确治疗理由的开放标签安慰剂 (OLP) 在缓解PMS症状方面表现出有效性.
- OLP代表了一个安全,有效和可接受的治疗选择为月经前综合征.
- 这些发现支持使用OLP作为PMS可行的治疗策略.
相关概念视频
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
Blinding
2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K


